Tags |
|
|
Links |
|
|
Main Subject - List Building - What is the Best List Building Web Business Model?
This is one of the most hotly contested questions online today. There are a number of different internet bu
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
siness models online today, including the content model, the affiliate model, the single product model, mult
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ple product model, catalogue model, list based model, and the sales funnel model.
List building can be inco
List building can be inco
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
rporated into any of these models, and the models themselves can be mixed and matched to come up with your o
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
n unique model. What I will do now is give you a brief description of each of these models, and then give y
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
u some ideas on how these models can fit together, and how to choose the best one for your business.
Conten
Conten
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
t Based Web Business Model
The content based web business model is a model that centers its profitability a
The content based web business model is a model that centers its profitability a
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ound web based content, or information, and primarily sells advertising on its web site for its monetization
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
. By providing useful content to web users, the web sites build up traffic, and advertisers will generally
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ay to have their ads show on web sites that have reasonable traffic. Over the past few years search engine
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
ay-per-click companies like Overture and Adwords have made monetizing these web sites more popular, by makin
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
g the advertising process easy. Rather than individually negotiate contracts with individual advertisers, w
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
b site owners can allow the pay-per-click companies to do that for them, and they can simply place the adver
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
tisers ad copy on their web sites, and are paid a specified amount by the pay-per-click companies when someo
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
e visits, or clicks on, the ad.
This is the one model that is the least compatible with a list building str
This is the one model that is the least compatible with a list building str
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
cture, although some web business owners have built lists and sent their list traffic to content pages for t
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
he purpose of generating advertising revenue. My guess is that this would be the least – profitable monetiza
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
ion of a list building campaign, because my experience has been that the pay-per-click monetization per visi
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
tor is lower than a sales page monetization. Obviously, with the right list and proper targeting of the ads
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
on the content pages, this could possibly be improved, but it would certainly not be my first recommendation
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.mainsubjects.org.ua/article/71408/mainsubjects-List-Building--What-is-the-Best-List-Building-Web-Business-Model.html">List Building - What is the Best List Building Web Business Model?</a>
BB link (for phorums):
[url=http://www.mainsubjects.org.ua/article/71408/mainsubjects-List-Building--What-is-the-Best-List-Building-Web-Business-Model.html]List Building - What is the Best List Building Web Business Model?[/url]
Related Articles:
Wrongful Termination: Were You Wrongfully Terminated?
Blog Tutorial - How To Create A Blog
How to Make Money From Someone Else's Product Launch Without Being An Affiliate
Bookmark it:
|